Growth Metrics

Whitehawk Therapeutics (WHWK) Cash from Investing Activities (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Cash from Investing Activities for 7 consecutive years, with $16.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 28.27% to $16.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, down 52.82% year-over-year, with the annual reading at $11.9 million for FY2025, 52.82% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $16.8 million at Whitehawk Therapeutics, up from -$91.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $115.5 million in Q1 2025, with the low at -$91.6 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is $706833.3, with a median of $4.4 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 183332.61% in 2022, then surged 71095.65% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$46000.0 in 2021, then tumbled by 183332.61% to -$84.4 million in 2022, then skyrocketed by 104.32% to $3.6 million in 2023, then soared by 259.91% to $13.1 million in 2024, then increased by 28.27% to $16.8 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $16.8 million, -$91.6 million, and -$28.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.